Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating flu or hyperpyrexia caused by bacterial virus

A technology of bacterial virus and composition, applied in the field of pharmaceuticals, to achieve good thermal stability and antifreeze performance, good curative effect, and the effect of enhancing the body's immunity

Active Publication Date: 2012-07-11
ANIMAL MEDICINE SICHUAN FEIYANG
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But so far, there is no literature report at home and abroad on the pharmaceutical composition made of baicalin, astragalus polysaccharide and diclofenac for the treatment of influenza or high fever symptoms caused by bacterial viruses

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating flu or hyperpyrexia caused by bacterial virus
  • Pharmaceutical composition for treating flu or hyperpyrexia caused by bacterial virus
  • Pharmaceutical composition for treating flu or hyperpyrexia caused by bacterial virus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Embodiment 1, the preparation of combining Chinese and Western medicine compound powder

[0017] (1) Prescription

[0018] A 1 : Astragalus polysaccharide (calculated as glucose) 1g, baicalin 2g, diclofenac 2g, soluble starch 95g;

[0019] A 2 : Astragalus polysaccharide (calculated as glucose) 1g, baicalin 3g, diclofenac 3g, soluble starch 93g;

[0020] A 3 : Astragalus polysaccharide (calculated as glucose) 2g, baicalin 4g, diclofenac 4g, soluble starch 90g;

[0021] (2) Preparation process

[0022] Mix the astragalus polysaccharide, baicalin and diclofenac in the prescribed amount evenly, then mix evenly with the soluble starch according to the method of equal-volume incremental dilution, and directly pack to prepare the compound powder combining traditional Chinese and western medicine.

Embodiment 2

[0023] Embodiment 2, the preparation of the pure Chinese medicine compound powder not containing diclofenac

[0024] (1) Prescription

[0025] B 1 : Astragalus polysaccharide (calculated as glucose) 1g, baicalin 2g, soluble starch 97g;

[0026] B 2 : Astragalus polysaccharide (calculated as glucose) 1g, baicalin 3g, soluble starch 96g;

[0027] B 3 : Astragalus polysaccharide (calculated as glucose) 2g, baicalin 4g, soluble starch 94g;

[0028] (2) Preparation process

[0029] The astragalus polysaccharide and baicalin in the prescribed amount were mixed evenly, and then mixed evenly with the soluble starch according to the method of equal volume incremental dilution, and directly divided into packages to obtain a pure Chinese medicine compound powder without diclofenac.

Embodiment 3

[0030] Embodiment 3, the preparation of diclofenac powder

[0031] (1) Prescription

[0032] C 1 : Diclofenac 2g, soluble starch 98g;

[0033] C 2 : Diclofenac 3g, soluble starch 97g;

[0034] C 3 : Diclofenac 4g, soluble starch 96g;

[0035] (2) Preparation process

[0036] Mix the diclofenac and soluble starch in the prescribed amount uniformly according to the equal-volume incremental dilution method, and directly pack to prepare the diclofenac powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of pharmacy, and discloses a pharmaceutical composition for treating flu or hyperpyrexia caused by bacterial virus. The pharmaceutical composition is composed of 1 part of astragalus polysaccharides by weight, 2-3 parts of baicalin by weight and 2-3 parts of diclofenac sodium by weight, and can be prepared with pharmaceutically acceptable carriers according to the conventional methods of pharmaceutical preparations to obtain various dosage forms such as powder, granules, tablets, oral liquid or injection and the like suitable for application for patients. The pharmaceutical composition for treating flu or hyperpyrexia caused by bacterial virus has the advantages of treatment of both principal and secondary aspects of disease, good curative effect, quick effect-taking speed and the like, and the actions of the astragalus polysaccharides and the baicalin on protecting the liver and promoting urination can alleviate the side effects of the diclofenac sodium such as gastrointestinal reaction, hepatorenal damage and the like, and also can reduce the occurrence of delay of diseases because the strong abirritation of the diclofenac sodium covers up the clinical symptoms of inflammation, ulcer and the like.

Description

technical field [0001] The invention belongs to the field of pharmacy and relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating influenza or high fever symptoms caused by bacteria and viruses. Background technique [0002] Influenza is an acute respiratory infection caused by influenza virus. It is a highly contagious and fast-spreading disease. It is a common and frequently-occurring disease of humans or livestock. Fever is a common symptom of many diseases. The causes of fever can be divided into two categories: acute infectious diseases and acute non-infectious diseases. The former is the most common, such as respiratory tract, digestive tract, urinary tract and skin diseases caused by bacteria and viruses. infection etc. Currently, there are many medicaments for treating flu or high fever symptoms caused by bacterial viruses, such as single or compound preparations of traditional Chinese medicines, single or compound prepara...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61K36/481A61P31/04A61P31/12A61P31/16A61P29/00A61K31/196
Inventor 肖国君陈力徐兴然杨大成张焱秦斌
Owner ANIMAL MEDICINE SICHUAN FEIYANG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com